NCT02439554View on ClinicalTrials.gov

Risk Factors for Medium-term Adverse Outcomes and Predictive Modeling for Breast Cancer Patients

CompletedOBSERVATIONAL
Enrollment

1,463

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Breast Cancer
Trial Locations (1)

48960

Hospital Galdakao-Usansolo, Galdakao

All Listed Sponsors
lead

Hospital Galdakao-Usansolo

OTHER_GOV

NCT02439554 - Risk Factors for Medium-term Adverse Outcomes and Predictive Modeling for Breast Cancer Patients | Biotech Hunter | Biotech Hunter